Biosensors International Ltd develops medical devices focused on interventional cardiology and endovascular applications, self-described as innovative in the healthcare sector.

Biosensors International Ltd

Domain Not Resolving

SSL by Default

Euro

Google Tag Manager

Apple Mobile Web Clips Icon

HSTS

DNSSEC

Global Site Tag

Mobile Non Scaleable Content

IPv6

Vice President, Scientific Affairs

Debashis Dutta

Senior VP, Human Asset Development

Pat Psy.D

Marketing and Product

Casey Fan

Quality

Chunxia Huang

Business Management

David Myszka

Sales and Support

Devin Yeow

Esther Tay

Kumano Hitoshi

Operations

Mandira Shah

Director of Regulatory Affairs

Marilyn Pourazar

Lu Yoh-Chie

Founder, Chairman & CEO

Association of Southeast Asian Nations (ASEAN) Acquired Companies With More Than 10 Employees

Association of Southeast Asian Nations (ASEAN) Companies With More Than 10 Employees (Top 10K)

Asia Medical Companies (Top 10K)

Asia Health Care Companies (Top 10K)

The Biosensors International group of companies develop, manufacture and market innovative medical devices for interventional cardiology and critical care procedures. Our aim is to improve patients' lives through pioneering medical technology that pushes forward the boundaries of innovation.

Hony Capital

Post-IPO Equity - Biosensors

Singapore

Central Region

Asia

Biosensors

Medical Sensor Market Growth Accelerates: USD 273.7 Bn Revenue by 2033 | Dimension Market Research

Biosensors Market to Grow at 9% CAGR Through 2032, Driven by Increased Healthcare Applications

Biosensors Market Growth Foreseen To Achieve USD 63.07 Bi...

Biosensors Market Growth Foreseen To Achieve USD 63.07 Billion Value By 2032, With An Estimated 9% C

Biosensors Market to Cross USD 52.93 Billion by 2030, Empowering Healthcare Advancements

Photoplethysmography (PPG) Biosensors Market to hit USD 1.2 Bn by 2032, says Global Market Insights Inc.

Point-of-care Biosensors Market Size to Surpass USD 159.01 Billion By 2032

Biosensors receives PMDA and FDA approval for BioFreedom stent

Drug-coated coronary stent system receives CE mark

Lab-on-a-chip offers faster means of identifying best plasma donors in COVID fight

A drug-eluting stent system used in interventional cardiology to treat coronary artery disease.

A coronary stent system designed for use in interventional cardiology procedures.

A polymer-free drug-coated stent used in the treatment of coronary artery disease.

An enhanced version of the BioFreedom stent, offering a polymer-free drug-coated solution.

A coronary stent system used in interventional cardiology.

A non-compliant balloon catheter used in interventional cardiology procedures.

India

Indonesia

Belarus

Europe

Taiwan

HTML5

Lightbox

jQuery

Apache Server

Google Analytics

Microsoft Outlook

Bootstrap

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 19, 2024 1:28 PM	2c594219
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 19, 2024 1:28 PM	41df38f2
crunchbase trigger	general	Nov 19, 2024 1:28 PM	f1dba8f9
crunchbase profile	general	Nov 20, 2024 3:04 AM	8132ea34
li profile	general	Nov 19, 2024 1:28 PM	f282ab2c
translate crunchbase fundingrounds	general	Nov 20, 2024 4:01 AM	23e82d95
peers	general	Nov 19, 2024 1:28 PM	7b0092d6
news basic	general	Nov 19, 2024 1:28 PM	cecc6879
bundesanzeiger	filings
financials download nd	financials
private financials	financials

BIOS

COM:BIOSENSORS

Biosensors International Ltd